JP2008526936A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526936A5
JP2008526936A5 JP2007550831A JP2007550831A JP2008526936A5 JP 2008526936 A5 JP2008526936 A5 JP 2008526936A5 JP 2007550831 A JP2007550831 A JP 2007550831A JP 2007550831 A JP2007550831 A JP 2007550831A JP 2008526936 A5 JP2008526936 A5 JP 2008526936A5
Authority
JP
Japan
Prior art keywords
efficient
developed
series
treatment
discloses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550831A
Other languages
English (en)
Other versions
JP2008526936A (ja
Filing date
Publication date
Priority claimed from GBGB0500604.4A external-priority patent/GB0500604D0/en
Application filed filed Critical
Publication of JP2008526936A publication Critical patent/JP2008526936A/ja
Publication of JP2008526936A5 publication Critical patent/JP2008526936A5/ja
Pending legal-status Critical Current

Links

Description

WO 04/106302 は、呼吸器疾患の処置に有用な一連の置換インドール類を開示している。
ある化合物のための、当業界で開示されたものより効率的な新規方法を開発した。

JP2007550831A 2005-01-13 2006-01-09 置換インドールの新規製造方法 Pending JP2008526936A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500604.4A GB0500604D0 (en) 2005-01-13 2005-01-13 Novel process
PCT/GB2006/000060 WO2006075139A2 (en) 2005-01-13 2006-01-09 Novel process for the preparation of substituted indoles

Publications (2)

Publication Number Publication Date
JP2008526936A JP2008526936A (ja) 2008-07-24
JP2008526936A5 true JP2008526936A5 (ja) 2009-02-12

Family

ID=34203986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550831A Pending JP2008526936A (ja) 2005-01-13 2006-01-09 置換インドールの新規製造方法

Country Status (15)

Country Link
US (1) US7781598B2 (ja)
EP (1) EP1844012A2 (ja)
JP (1) JP2008526936A (ja)
KR (1) KR20070104350A (ja)
CN (1) CN101102999B (ja)
AU (1) AU2006205697B2 (ja)
BR (1) BRPI0606639A2 (ja)
CA (1) CA2594391A1 (ja)
GB (1) GB0500604D0 (ja)
IL (1) IL183965A0 (ja)
MX (1) MX2007008348A (ja)
NO (1) NO20074047L (ja)
NZ (1) NZ556147A (ja)
WO (1) WO2006075139A2 (ja)
ZA (1) ZA200705216B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
EP2125722A2 (en) * 2006-05-26 2009-12-02 AstraZeneca AB Bi-aryl or aryl-heteroaryl substituted indoles
CN102482214B (zh) 2009-07-06 2014-08-27 阿斯利康(瑞典)有限公司 制备4-(乙酰基氨基)-3-[(4-氯-苯基)硫基]-2-甲基-1h-吲哚-1-乙酸的中间体和方法
US20140328861A1 (en) 2011-12-16 2014-11-06 Atopix Therapeutics Limited Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis
CN103288707B (zh) * 2013-05-28 2015-12-23 浙江大学 一种3-苯巯基吲哚衍生物的制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790679A (fr) 1971-11-03 1973-04-27 Ici Ltd Derives de l'indole
JPH0615542B2 (ja) 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
WO1993005020A1 (en) 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase
FR2692574B1 (fr) 1992-06-23 1995-06-23 Sanofi Elf Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
PL175788B1 (pl) 1993-02-24 1999-02-26 Merck & Co Inc Amidowe pochodne indolu i zawierające je kompozycje farmaceutyczne
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
TW472045B (en) 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
ZA987554B (en) 1997-08-21 2000-02-21 American Home Prod Methods for the solid phase synthesis of substituted indole compounds.
ZA9811672B (en) 1997-12-19 2000-06-19 Lilly Co Eli Hypoglycemic imidazoline compounds.
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
AU5886500A (en) 1999-06-23 2001-01-09 Sepracor, Inc. Indolyl-benzimidazole antibacterials, and methods of use thereof
AU7962200A (en) 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
CA2699568C (en) 1999-12-24 2013-03-12 Aventis Pharma Limited Azaindoles
JP2003535078A (ja) 2000-05-31 2003-11-25 アストラゼネカ アクチボラグ 血管損傷活性のあるインドール誘導体
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
EP1414442A1 (en) * 2001-08-07 2004-05-06 Smithkline Beecham Plc 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
US6933316B2 (en) * 2001-12-13 2005-08-23 National Health Research Institutes Indole compounds
JP4209332B2 (ja) 2002-02-01 2009-01-14 エフ.ホフマン−ラ ロシュ アーゲー α−1アゴニストとしての置換インドール
SE0200411D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
AU2003231509A1 (en) 2002-05-16 2003-12-02 Shionogi And Co., Ltd. Compound exhibiting pgd 2 receptor antagonism
TW200307542A (en) * 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0202463D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
JP4332151B2 (ja) * 2002-10-30 2009-09-16 メルク フロスト カナダ リミテツド ピリドピロリジンおよびピリドインドリジン誘導体
RU2350602C2 (ru) * 2002-12-03 2009-03-27 Ф.Хоффманн-Ля Рош Аг Аминоалкоксииндолы, как лиганды рецептора 5-нт6, для лечения заболеваний цнс
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
WO2005040114A1 (en) 2003-10-14 2005-05-06 Oxagen Limited Compounds having crth2 antagonist activity
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB2422831A (en) 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
EP2125722A2 (en) * 2006-05-26 2009-12-02 AstraZeneca AB Bi-aryl or aryl-heteroaryl substituted indoles
RU2008152763A (ru) 2006-06-08 2010-07-20 Ньюроки А/С (Dk) Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии
AU2007264114A1 (en) 2006-06-28 2008-01-03 Sanofi-Aventis New CXCR2 inhibitors

Similar Documents

Publication Publication Date Title
JP2008526936A5 (ja)
NO2020027I1 (no) glasdegib, eventuelt i form av et farmasøytisk akseptabelt salt, inkludert maleatsaltet
CY2016040I1 (el) Επιλογες θεραπειας για τη νοσο του fabry
IL195571A0 (en) Compounds for the treatment of periodontal disease
IL233925A0 (en) Pharmaceutical dose for oral administration in the form of tiny particles to prevent incorrect use
DK1656346T3 (da) 1,2,3,4-tetrasubstituerede indol til behandling af luftvejssygdomme
PL1993985T3 (pl) Sposób wytwarzania 1,2-propanodiolu
NO343834B1 (no) Farmasøytisk preparat omfattende en omega-karboksylarylsubstituert difenylurea for behandling av cancer
JP2009039101A5 (ja)
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL184456A0 (en) Dosage form for treating gastrointestinal disorders
JP2007525988A5 (ja)
JP2007520565A5 (ja)
JP2010525055A5 (ja)
IL178815A0 (en) The treatment of respiratory disease
JP2008519810A5 (ja)
EP1951710A4 (en) PHOTOCHEMICAL PROCESSES AND PHOTOACTIVE COMPOUNDS FOR MODIFYING SURFACES
GB0410399D0 (en) The treatment of respiratory disease
IL185444A0 (en) Novel drugs for treating respiratory diseases
PL2366393T3 (pl) Roflumilast do leczenia nadciśnienia płucnego
HU0500145D0 (en) Composition for the treatment of oral diseases
DE602006011649D1 (de) Neue indolizinderivate, verfahren zu deren herstellung und therapeutische zusammensetzungen, die diese enthalten
EP1872849A4 (en) ALCOHOL-RESISTANT EMULSION AND PROCESS FOR PRODUCING THE SAME
EP1942909A4 (en) METHODS OF TREATING RESPIRATORY DISORDERS
GB0400802D0 (en) Compounds for the treatment of disease